Exploring the Tumor Microenvironment in Cancer Treatment

Ronald Herbst, CSO of Pyxis Oncology discusses the potential of immunotherapy, understanding T cells in the tumor microenvironment, and ADCs in the company's pipeline.

    • Tags:

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Q: